AAM
OSIR

Alpine Associates Management’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Alpine Associates Management’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-1,233,589
Closed -$23.4M – 77
2019
Q1 		$23.4M Buy
+1,233,589
New +$20M 0.77% 27

Other funds holding OSIR

FGAM
Financial Gravity Asset Management Lakeway, Texas $562M AUM

Alpine Associates Management's OSIR Position: Q2 2019 in Review

Alpine Associates Management sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 1,233,589 shares — an estimated $23.4M sold.

Alpine Associates Management first reported a position in OSIR in Q1 2019 and held it in 1 quarter. The position peaked at $23.4M in Q1 2019. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.

  • Alpine Associates Management reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • Alpine Associates Management sold 1,233,589 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $23.4M.
  • Alpine Associates Management first reported a position in Osiris Therapeutics, Inc. Common Stock in Q1 2019 and held it in 1 quarter.
  • Alpine Associates Management's Osiris Therapeutics, Inc. Common Stock position peaked at $23.4M in Q1 2019.
  • 1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.

Based on Alpine Associates Management's 13F filing for Q2 2019, filed 12 Aug 2019.